Thomas Strüngmann
Gründer bei ATS Beteiligungsverwaltung GmbH
Profil
Thomas Strüngmann was the founder of ATS Beteiligungsverwaltung GmbH, where he served as the Chief Executive Officer from 2010 to 2018.
He was also the founder of Hexal AG and AT Newtec GmbH.
Dr. Strüngmann's current jobs included being a Co-Managing Director at Klinge Pharma GmbH, Dr. Ernst Strüngmann Foundation gGmbH, Projektgesellschaft St. Anna 16 mbH, and Klinge Pharma GmbH (Bayern).
His former positions include being the Chairman of Eon Labs, Inc., Chairman-Supervisory Board of Santo Holding AG, Co-Managing Director of ATHOS Service GmbH, Jossa Arznei GmbH, and AT Impf GmbH, and Member-Supervisory Board of Wacker Chemie AG.
Dr. Strüngmann also holds a position as a Member-Supervisory Board at Formycon AG from 2022 to 2023.
He obtained a doctorate degree from the University of Augsburg and an undergraduate degree from Ludwig-Maximilians-Universität München.
Dr. Strüngmann is also the founder of Hexal AG, AT Newtec GmbH.
Aktive Positionen von Thomas Strüngmann
| Unternehmen | Position | Beginn |
|---|---|---|
ATS Beteiligungsverwaltung GmbH
 ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Gründer | 01.01.2006 |
Klinge Pharma GmbH (Bayern)
 Klinge Pharma GmbH (Bayern) Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn. | Vorstandsvorsitzender | - |
Klinge Pharma GmbH
 Klinge Pharma GmbH Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany. | Vorstandsvorsitzender | - |
Dr. Ernst Strüngmann Foundation gGmbH
 Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Vorstandsvorsitzender | - |
Projektgesellschaft St. Anna 16 mbH
 Projektgesellschaft St. Anna 16 mbH Financial ConglomeratesFinance Projektgesellschaft St. Anna 16 mbH is a German company that provides financial services. The private company is based in Unterfoehring, Germany. The CEOs of the company are Thomas Strüngmann, Stefan Legat. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Thomas Strüngmann
| Unternehmen | Position | Ende |
|---|---|---|
| FORMYCON AG | Direktor/Vorstandsmitglied | 25.07.2023 |
Jossa Arznei GmbH
 Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Vorstandsvorsitzender | 09.08.2018 |
Santo Holding AG
 Santo Holding AG Financial ConglomeratesFinance Santo Holding AG operates as a holding company with interest in providing investments services. The firm provides loans, operating leases and acquires, holds, and sells real estate property. It invests in biotechnology, pharmaceuticals, life sciences, and healthcare companies. The company was founded in 2001 and is headquartered in Zurich, Switzerland. | Vorsitzender | - |
AT Newtec GmbH
 AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Vorstandsvorsitzender | - |
| ░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Thomas Strüngmann
| Ludwig-Maximilians-Universität München | Undergraduate Degree |
| University of Augsburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| WACKER CHEMIE AG | Process Industries |
| FORMYCON AG | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Eon Labs, Inc.
 Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Health Technology |
ATS Beteiligungsverwaltung GmbH
ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Finance |
Athos Service GmbH
 Athos Service GmbH Financial ConglomeratesFinance Athos Service GmbH operates as an investment company which focuses on the pharmaceutical business. It offers personal investment trust management services. The firm also provides financial advisory services. The company is headquartered in Munich, Germany. | Finance |
AT Impf GmbH
 AT Impf GmbH Finance/Rental/LeasingFinance AT Impf GmbH offers purchasing services. It also provides sales and acquisition services. The company was founded on November 12, 2008 and is headquartered in Munich, Germany. | Finance |
AT Newtec GmbH
AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Finance |
Jossa Arznei GmbH
Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Health Technology |
Santo Holding AG
Santo Holding AG Financial ConglomeratesFinance Santo Holding AG operates as a holding company with interest in providing investments services. The firm provides loans, operating leases and acquires, holds, and sells real estate property. It invests in biotechnology, pharmaceuticals, life sciences, and healthcare companies. The company was founded in 2001 and is headquartered in Zurich, Switzerland. | Finance |
Klinge Pharma GmbH (Bayern)
Klinge Pharma GmbH (Bayern) Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn. | Health Technology |
Klinge Pharma GmbH
Klinge Pharma GmbH Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany. | Health Technology |
Dr. Ernst Strüngmann Foundation gGmbH
Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Commercial Services |
Projektgesellschaft St. Anna 16 mbH
Projektgesellschaft St. Anna 16 mbH Financial ConglomeratesFinance Projektgesellschaft St. Anna 16 mbH is a German company that provides financial services. The private company is based in Unterfoehring, Germany. The CEOs of the company are Thomas Strüngmann, Stefan Legat. | Finance |
